comparemela.com

Latest Breaking News On - Y mabs therapeutics inc - Page 8 : comparemela.com

Y-mAbs Therapeutics (NASDAQ:YMAB) Trading 2 8% Higher

Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) were up 2.8% on Tuesday . The company traded as high as $12.50 and last traded at $12.45. Approximately 32,320 shares changed hands during trading, a decline of 92% from the average daily volume of 411,775 shares. The stock had previously closed at $12.11. Analysts […]

United statesAcadian asset managementExchange traded conceptsUnisuper management pty ltdY mabs therapeutics incPrincipal financial group incY mabs therapeuticsGet free reportAbs therapeuticsThomas gadAsset managementTraded conceptsSuper management pty ltdPrincipal financial groupFinancial groupY mabs therapeutics daily

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Receives Consensus Recommendation of Hold from Brokerages

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) has been given a consensus recommendation of “Hold” by the seven analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The […]

United statesTower research capitalAvestar capitalRussell investments group ltdChina universal asset management coLazard asset managementY mabs therapeutics incY mabs therapeutics company profileY mabs therapeuticsGet free reportAbs therapeuticsThomas gadResearch capitalUniversal asset managementInvestments groupAsset management

Anti-Cancer Monoclonal Antibodies Market to Reach $95 99

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) The

United statesDaiichi sankyoAsia pacificEli lillyErytech pharmaPfizer incMacrogenics incAmgen incGenentech incSpectrum pharmaceuticals incAbbvie incRoche holdingGilead sciences incImmunogen incRegeneron pharmaceuticalsBristol myers squibb company

Analysis Of Global Pediatric Neuroblastoma Treatment Markets, 2018-2033: Unveiling Trends In Emerging Therapies, Personalized Medicine, Access To Trea

Analysis Of Global Pediatric Neuroblastoma Treatment Markets, 2018-2033: Unveiling Trends In Emerging Therapies, Personalized Medicine, Access To Trea
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaUnited kingdomEli lillyDepartment of healthDrug administrationClarity pharmaceuticalsAstellas pharma incJude children research hospitalAmerican society of clinical oncologyPharma united kingdom ltdRenaissance pharma ltdBayer agAmgen incBaxter international incBristol myers squibb company

Y-Mabs Therapeutics To Present At 42Nd Annual J P Morgan Healthcare Conference

Y-Mabs Therapeutics To Present At 42Nd Annual J P Morgan Healthcare Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesMichael rossiY mabs therapeutics incSecurities exchangeCompany annual report on formCompany investor relationsAssembly disassemblyGlobe newswirey mabs therapeutics incCompany quarterly report on formAbs therapeuticsChief executive officerHealthcare conferenceInvestor relationsSelf assembly disassemblySecurities act

vimarsana © 2020. All Rights Reserved.